Marshall Wace
LJPC

Marshall Wace’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Marshall Wace’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-15,572
Closed -$67K – 3699
2021
Q2 		$67K Buy
+15,572
New +$66.7K ﹤0.01% 2560
2019
Q2 		– Sell
-144,977
Closed -$933K – 2120
2019
Q1 		$933K Buy
144,977
+72,339
+100% +$471K 0.01% 952
2018
Q4 		$685K Buy
+72,638
New +$1.09M 0.01% 1015

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
KT
Kevin Tang $783 AUM 75.59% 1-Year Est. Return

Marshall Wace's LJPC Position: Q3 2021 in Review

Marshall Wace sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2021, closing a stake of 15,572 shares — an estimated $67K sold.

Marshall Wace first reported a position in LJPC in Q4 2018 and held it in 3 quarters. The position peaked at $933K in Q1 2019. 54 funds tracked by Wall St. Rank hold LJPC as of Q3 2021.

  • Marshall Wace reported no remaining La Jolla Pharmaceutical Company position as of Q3 2021 after selling out during the quarter.
  • Marshall Wace sold 15,572 La Jolla Pharmaceutical Company shares in Q3 2021, an estimated $67K.
  • Marshall Wace first reported a position in La Jolla Pharmaceutical Company in Q4 2018 and held it in 3 quarters.
  • Marshall Wace's La Jolla Pharmaceutical Company position peaked at $933K in Q1 2019.
  • 54 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2021.

Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.